Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Opioid drugmaker Insys Therapeutics files for bankruptcy after kickback probe

      Opioid drugmaker Insys Therapeutics files for bankruptcy after kickback probe

      Medical Dialogues Bureau11 Jun 2019 9:00 AM IST
      The filing in U.S. Bankruptcy Court in the District of Delaware made Insys Therapeutics the first drug manufacturer to turn to bankruptcy due to legal...
      USFDA okays marketing of first medical device IB-Stim to treat IBS pain

      USFDA okays marketing of first medical device IB-Stim to treat IBS pain

      Medical Dialogues Bureau10 Jun 2019 9:45 AM IST
      The IB-Stim is a prescription-only medical device comprised of a small single-use electrical nerve stimulator that is placed behind the patient’s ear....
      Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

      Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

      Medical Dialogues Bureau9 Jun 2019 11:15 AM IST
      The commission also said in its view, diabetes was a lifestyle disease in India and the whole insurance claim (Mediclaim) cannot be rejected only...
      Healthians launches operations in Maharashtra; plans to infuse over Rs 34 crore to expand services

      Healthians launches operations in Maharashtra; plans to infuse over Rs 34 crore to expand services

      Medical Dialogues Bureau9 Jun 2019 9:40 AM IST
      Healthians is looking for more acquisitions to fuel its aggressive growth plans and plans to invest over USD 5 million to expand its services to...
      Sanofi loses German patent case against Amgen over cholesterol drug Praluent

      Sanofi loses German patent case against Amgen over cholesterol drug Praluent

      Medical Dialogues Bureau9 Jun 2019 9:30 AM IST
      In the latest setback for Sanofi in the drawn-out patent dispute with Amgen, which is selling its rival drug Repatha, the German court ruled that...
      AstraZeneca blood cancer drug Calquence meets primary goal in late-stage trial

      AstraZeneca blood cancer drug Calquence meets primary goal in late-stage trial

      Medical Dialogues Bureau9 Jun 2019 9:10 AM IST
      The drug, Calquence, is a cornerstone product for AstraZeneca in haematology and its accelerated U.S. approval in 2017 marked its first entry into...
      Tighter EU rules could trigger antibiotic shortage; says Fresenius

      Tighter EU rules could trigger antibiotic shortage; says Fresenius

      Medical Dialogues Bureau9 Jun 2019 9:00 AM IST
      Fresenius said that under the draft proposals, the bulk-freeze-dryers that is used to produce the antibiotic would have to be sterilised more...
      Over Rs 74 crore fine on Himalaya, Intas Pharma, 2 Chemist Associations for anti-competitive trade practices

      Over Rs 74 crore fine on Himalaya, Intas Pharma, 2 Chemist Associations for anti-competitive trade practices

      Medical Dialogues Bureau8 Jun 2019 2:35 PM IST
      As per the CCI order, Himalaya Drug was fined Rs 18.59 crore while its three senior officials were fined a total of nearly Rs 4 lakh. Besides, Intas...
      GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

      GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

      Medical Dialogues Bureau8 Jun 2019 10:00 AM IST
      The price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough...
      Aurobindo Pharma, subsidiary made party to litigation proceedings in US

      Aurobindo Pharma, subsidiary made party to litigation proceedings in US

      Medical Dialogues Bureau8 Jun 2019 9:45 AM IST
      The company was reacting to a media report as per which, bankrupt US drug firm Aceto Corporation has accused Aurobindo Pharma and its founder P V...
      Sanofi poised to appoint Novartis Paul Hudson as CEO

      Sanofi poised to appoint Novartis' Paul Hudson as CEO

      Medical Dialogues Bureau8 Jun 2019 9:44 AM IST
      PARIS: Sanofi is poised to appoint Paul Hudson, a top executive with Switzerland's Novartis, to become the French drugmaker's next CEO from Sept. 1, a...
      Opioid maker agrees to pay $225 million to settle federal probes

      Opioid maker agrees to pay $225 million to settle federal probes

      Medical Dialogues Bureau8 Jun 2019 9:00 AM IST
      WASHINGTON: An opioid manufacturer has agreed to pay $225 million to resolve federal investigations into allegations that it paid kickbacks and used...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok